Biology Reference
In-Depth Information
46. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW,
McCarley RW. Adenosine: a mediator of the sleep-inducing effects of prolonged wake-
fulness. Science . 1997;276:1265-1268.
47. Urade Y, Hayaishi O. Prostaglandin D2 and sleep/wake regulation. Sleep Med Rev .
2011;15:411-418.
48. Saper CB, Romanovsky AA, Scammell TE. Neural circuitry engaged by prostaglandins
during the sickness syndrome. Nat Neurosci . 2012;15:1088-1095.
49. McCarley RW. Neurobiology of REM and NREM sleep. Sleep Med . 2007;8:302-330.
50. Porkka-Heiskanen T, Strecker RE, McCarley RW. Brain site-specificity of extracellular
adenosine concentration changes during sleep deprivation and spontaneous sleep: an
in vivo microdialysis study. Neuroscience . 2000;99:507-517.
51. Zeitzer JM, Moreales-Villagran A, Maidment NT, et al. Extracellular adenosine in the
human brain during sleep and sleep deprivation: an in vivo microdialysis study. Sleep .
2006;29:455-461.
52. Fredholm BB, B ¨ ttig K, Holm´n J, Nehlig A, Zvartau EE. Actions of caffeine in the
brain with special reference to factors that contribute to its widespread use. Pharmcol
Rev . 1999;51:83-133.
53. Lazarus M, Shen HY, Cherasse Y, et al. Arousal effect of caffeine depends on adenosine
A2A receptors in the shell of the nucleus accumbens. J Neurosci . 2011;31:10067-10075.
54. Klerman EB, Davis JB, Duffy JF, Dijk D-J, Kronauer RE. Older people awaken more
frequently but
fall back asleep at
the same rate as younger people.
Sleep .
2004;27:793-798.
55. Prinz PN, Peskind ER, Vitaliano PP, et al. Changes in the sleep and waking EEGs of
nondemented and demented elderly subjects. J Am Geriatr Soc . 1982;30:86-93.
56. Bianchetti A, Scuratti A, Zanetti O, et al. Predictors of mortality and institutionalization
in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit.
Dementia . 1995;6:108-112.
57. Friedman L, Zeitzer JM, Lin L, et al. Hypocretin-1 is inversely associated with wake
fragmentation in Alzheimer's disease. Neurology . 2007;68:793-794.
58. Panula P, Pirvola U, Auvinen S, Airaksinen MS. Histamine-immunoreactive nerve
fibers in the rat brain. Neuroscience . 1989;28:585-610.
59. Steininger TL, Alam MN, Gong H, Szymusiak R, McGinty D. Sleep-waking discharge
of neurons
in the posterior lateral hypothalamus of
the albino rat.
Brain Res .
1999;840:138-147.
60. Lin JS. Brain structures and mechanisms involved in the control of cortical activation and
wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons.
Sleep Med Rev . 2000;4:471-503.
61. Passani MB, Lin J-S, Hancock A, Crochet S, Blandina P. The histamine H3 receptor as a
novel
therapeutic target
for cognitive and sleep disorders. Trends Pharmacol Sci .
2004;25:618-625.
62. Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release medi-
ated by a novel class (H3) of histamine receptor. Nature . 1983;302:832-837.
63. Itoh Y, Oishi R, Nishibori M, Saeki K. Characterization of histamine release from the rat
hypothalamus as measured by in vivo microdialysis. J Neurochem . 1991;56:769-774.
64. Lin J-S, Dauvilliers Y, Arnulf I, et al. An inverse agonist of the histamine H3 receptor
improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol
Dis . 2008;30:74-83.
65. Sherin JE, Elmquist JK, Torrealba F, Saper CB. Innervation of histaminergic
tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral
preoptic nucleus of the rat. J Neurosci . 1998;18:4705-4721.
66. Sherin JE, Shiromani PJ, McCarley RW, Saper CB. Activation of ventrolateral preoptic
neurons during sleep. Science . 1996;271:216-219.
 
 
 
 
Search WWH ::




Custom Search